Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	+1,07%	-3,49%	-3,35%	+11,75%	46,86 mld.
REVOLUTION MEDICINES, INC.	+0,25%	+1,65%	+399,22%	+647,65%	40,23 mld.
BEONE MEDICINES AG	-0,27%	+4,45%	+11,81%	+60,81%	36,23 mld.
IQVIA HOLDINGS INC.	+0,35%	+0,87%	+4,46%	-10,31%	34,72 mld.
CELLTRION, INC.	+3,14%	+1,02%	+4,76%	+43,00%	27,89 mld.
MEDPACE HOLDINGS, INC.	-0,73%	+11,84%	+34,39%	+134,44%	16,79 mld.
ASCENDIS PHARMA A/S	+0,47%	-2,74%	-	-	16,74 mld.
EUROFINS SCIENTIFIC SE	+0,42%	-5,52%	-3,43%	+9,10%	13,12 mld.
ICON PUBLIC LIMITED COMPANY	-2,68%	-2,49%	-11,36%	-34,51%	12,7 mld.
Gemiddelde	+0,20%	+0,83%	+54,56%	+107,74%	27,25 mld.
Gewogen gemiddelde per kap.	+0,48%	+0,91%	+74,42%	+138,21%